Clinical trial
Biomarkers for Risk Stratification of Patients With ST-elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
NCT03735719 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers for Risk Stratification of Patients With ST-elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
- Lead sponsor
- Medical University of Warsaw
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2014
- Completion date
- January 31, 2021
- Enrollment
- 136 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biomarkers, cardiovascular diseases, heart diseases, heart failure, pathologic processes, primary percutaneous coronary intervention, st segment elevation myocardial infarction